Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. The metric has seen a significant gain of 58.43% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 90.42%. Over the past 30 days, the price of VRNA has fallen by 14.44%. And in the last five days, it has surged by 13.95%.
Verona Pharma Plc ADR saw a rather consistency, in terms of market performance. The company’s stock reached its highest point at $30.73 on 10/03/24, while the lowest price for the same duration was marked at $11.39 on 05/30/24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
52-week price history of VRNA Stock
Examining the 52-week high and low prices can provide valuable insights into a stock’s current status and future performance. Verona Pharma Plc ADR’s current trading price is 2.49% away from its 52-week high, while its distance from the 52-week low is 176.51%. The stock’s price range during this time has been between $11.39 and $30.73. The trading volume for the Healthcare sector company’s shares reached about 0.67 million for the day, which was lower than the average daily volume of 1.18 million over the last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Verona Pharma Plc ADR (VRNA) has experienced a quarterly rise of 95.50% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.55B and boasts a workforce of 79 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 21.11, with a change in price of +16.55. Similarly, Verona Pharma Plc ADR recorded 1,272,808 in trading volume during the last 100 days, posting a change of +111.45%.
VRNA’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for VRNA stands at 1.30. Similarly, the long-term debt-to-equity ratio is also 1.29.
VRNA Stock Stochastic Average
Today, Verona Pharma Plc ADR’s raw stochastic average for the past 50 days stands at 96.77%, indicating a rise from the raw stochastic average of the last 20 days, which was 93.21%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 77.62% and 72.23% respectively.
